STAFF PROFILE
Professor Steven Bozinovski
Position:
Professor
College / Portfolio:
STEM College
School / Department:
STEM|Health and Biomedical Sciences
Phone:
+61399256674
Campus:
Bundoora West
Contact me about:
Research supervision
- To, E.,Erlich, J.,Liong, F.,Liong, S.,Oseghale, S.,Miles, M.,Papagianis, P.,Quinn, K.,Bozinovski, S.,Vlahos, R.,Selemidis, S., et al, . (2022). Therapeutic Targeting of Endosome and Mitochondrial Reactive Oxygen Species Protects Mice From Influenza Virus Morbidity In: Frontiers in Pharmacology, 13, 1 - 12
- Mou, K.,Chan, S.,Brassington, K.,Dobric, A.,De Luca, S.,Seow, H.,Selemidis, S.,Bozinovski, S.,Vlahos, R. (2022). Influenza A Virus-Driven Airway Inflammation may be Dissociated From Limb Muscle Atrophy in Cigarette Smoke-Exposed Mice In: Frontiers in Pharmacology, 13, 1 - 18
- Aujla, S.,Aloe, C.,Vannitamby, A.,Wang, H.,Vlahos, R.,Selemidis, S.,Bozinovski, S., et al, . (2022). Programmed Death-Ligand 1 Copy Number Loss in NSCLC Associates With Reduced Programmed Death-Ligand 1 Tumor Staining and a Cold Immunophenotype In: Journal of Thoracic Oncology, 17, 675 - 687
- Dobric, A.,De Luca, S.,Seow, H.,Wang, H.,Brassington, K.,Chan, S.,Mou, K.,Erlich, J.,Liong, S.,Selemidis, S.,Spencer, S.,Bozinovski, S.,Vlahos, R. (2022). Cigarette Smoke Exposure Induces Neurocognitive Impairments and Neuropathological Changes in the Hippocampus In: Frontiers in Molecular Neuroscience, 15, 1 - 16
- Fung, N.,Wang, H.,Vlahos, R.,Wilson, N.,Lopez, A.,Owczarek, C.,Bozinovski, S. (2022). Targeting the human ßc receptor inhibits inflammatory myeloid cells and lung injury caused by acute cigarette smoke exposure In: Respirology, 27, 617 - 629
- Brassington, K.,Chan, S.,De Luca, S.,Dobric, A.,Almerdasi, S.,Mou, K.,Seow, H.,Oseghale, S.,Bozinovski, S.,Selemidis, S.,Vlahos, R. (2022). Ebselen abolishes vascular dysfunction in influenza A virus-induced exacerbations of cigarette smoke-induced lung inflammation in mice In: Clinical Science, 136, 537 - 555
- Brassington, K.,Selemidis, S.,Bozinovski, S.,Vlahos, R. (2022). Chronic obstructive pulmonary disease and atherosclerosis: common mechanisms and novel therapeutics In: Clinical Science, 136, 405 - 423
- Pournaras, N.,Andersson, A.,Melissa, K.,Bozinovski, S., et al, . (2022). Glucose Homeostasis in Relation to Neutrophil Mobilization in Smokers with COPD In: International Journal of COPD, 17, 1179 - 1194
- Ruwanpura, S.,McLeod, L.,Dousha, L.,Bozinovski, S.,Vlahos, R., et al., . (2022). Cross-talk between IL-6 trans-signaling and AIM2 inflammasome/IL-1ß axes bridge innate immunity and epithelial apoptosis to promote emphysema In: Proceedings of the National Academy of Sciences of the United States of America, 119, 1 - 12
- Erlich, J.,To, E.,Luong, R.,Liong, F.,Liong, S.,Oseghale, O.,Miles, M.,Bozinovski, S.,Vlahos, R.,Chan, S.,Selemidis, S., et al., . (2022). Glycolysis and the Pentose Phosphate Pathway Promote LPS-Induced NOX2 Oxidase- and IFN-ß-Dependent Inflammation in Macrophages In: Antioxidants, 11, 1 - 14
- Silicosis – Harnessing new ideas to conquer the re-emergence of an ancient lung disease - The SHIELD Study (Administered by University of Queensland). Funded by: Medical Research Future Fund from (2022 to 2025)
- Novel mRNA therapeutic strategies for reprogramming tumour associated macrophages in lung cancer. Funded by: mRNA Victorian Medical Research Acceleration Fund from (2022 to 2024)
- Targeting oxidant-dependent pathways to treat skeletal muscle wasting in COPD. Funded by: National Health and Medical Research Council (NHMRC) Project Grants 2017 (for funding commencing in 2018) from (2018 to 2023)
- FPR2 is a therapeutic target in lung cancer. Funded by: National Health and Medical Research Council (NHMRC) Project Grants 2017 (for funding commencing in 2018) from (2018 to 2022)
- Novel pharmacological strategies to treat cognitive dysfunction in COPD. Funded by: National Health and Medical Research Council (NHMRC) Project Grants 2017 (for funding commencing in 2018) from (2018 to 2022)
4 PhD Current Supervisions6 PhD Completions and 1 Masters by Research Completions
Asthma, Chronic obstructive pulmonary disease, Lung inflamation, Oxidative stress, Respiratory infections, Emphysema